Actuate Therapeutics, Inc.

NasdaqGM:ACTU Stock Report

Market Cap: US$58.6m

Actuate Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:ACTU Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
05 Jan 26SellUS$1,624,000Kairos Venture Investments, LLCCompany280,000US$5.80
27 Jun 25BuyUS$499,996Bios Equity Partners LPCompany71,428US$7.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ACTU?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,119,1974.82%
Hedge Funds1,300,0005.59%
Institutions1,777,1437.65%
General Public6,642,64828.6%
VC/PE Firms12,404,34053.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 19%.

Top Shareholders

Top 25 shareholders own 70.9% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
43.2%
Bios Equity Partners LP
10,049,996US$25.3m0%23.43%
10.1%
Kairos Venture Investments, LLC
2,354,344US$5.9m-10.6%no data
5.59%
Voss Capital, LP
1,300,000US$3.3m45%0.21%
3.36%
Daniel Schmitt
780,921US$2.0m26.2%no data
2.28%
The Vanguard Group, Inc.
529,111US$1.3m67.4%no data
1.86%
BlackRock, Inc.
432,041US$1.1m53.2%no data
0.89%
Geode Capital Management, LLC
207,744US$523.5k42.9%no data
0.5%
Andrew Mazar
115,468US$291.0k0%no data
0.44%
Northern Trust Global Investments
101,423US$255.6k18.7%no data
0.41%
Texas Capital Bank Wealth Management Services, Inc.
94,592US$238.4k0%0.02%
0.33%
Aaron Glenn Fletcher
77,085US$194.3k0%no data
0.33%
Daniel Zabrowski
76,348US$192.4k0%no data
0.3%
Leslie Kreis
69,375US$174.8k0%no data
0.24%
State Street Global Advisors, Inc.
56,290US$141.9k12.8%no data
0.15%
Royal Bank of Canada
35,263US$88.9k172%no data
0.13%
Bridgeway Capital Management, LLC
30,982US$78.1k0%no data
0.1%
Charles Schwab Investment Management, Inc.
23,841US$60.1k61.5%no data
0.094%
The Rock Creek Group, LP
21,759US$54.8k0%0.01%
0.087%
Wells Fargo & Company
20,146US$50.8k48.8%no data
0.086%
SFMG, LLC
20,000US$50.4k17.7%no data
0.082%
The Gleason Group, Inc.
19,028US$47.9k0%0.01%
0.08%
Northwestern Mutual Wealth Management Company
18,518US$46.7k-4.06%no data
0.072%
Jane Street Group, LLC
16,625US$41.9k0%no data
0.064%
Barclays PLC
14,946US$37.7k68.6%no data
0.056%
Morgan Stanley
13,119US$33.1k72%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/03/12 23:36
End of Day Share Price 2026/03/12 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Actuate Therapeutics, Inc. is covered by 4 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mayank MamtaniB. Riley Securities, Inc.
Gum-Ming LoweCraig-Hallum Capital Group LLC
Swayampakula RamakanthH.C. Wainwright & Co.